» Articles » PMID: 34336015

Epidemiology of Hypertensive Heart Disease in Poland: Findings from the Global Burden of Disease Study 2016

Overview
Journal Arch Med Sci
Specialty General Medicine
Date 2021 Aug 2
PMID 34336015
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hypertension may cause target organ damage leading to hypertensive heart disease (HHD). The burden caused by HHD in Poland has not been studied systematically. The purpose of this study was to describe the burden of HHD in Poland in terms of prevalence, mortality, disability-adjusted life years lost (DALY) and key risk factors.

Material And Methods: Data were obtained from the Global Burden of Diseases, Injuries and Risk Factors (GBD) Study database. The GBD uses a wide range of data sources and complex statistical methods to estimate disease burden for all countries by age, sex, and year. HHD was defined by ICD-9 codes 402-402.91 and ICD-10 codes I11-I11.9. From the GBD 2016 estimates, we extracted data for Poland between 1990 and 2016.

Results: Hypertensive heart disease is the fourth most important cause of cardio- and cerebrovascular death, after ischemic heart disease, stroke and cardiomyopathy. In 2016, there were about 180 000 people diagnosed with HHD in Poland and close to 5000 HHD-related deaths. HHD prevalence increased from 0.29% in 1990 to 0.47% in 2016 and was higher in women, while mortality increased from 11.2 to 12.7 per 100 000, largely due to population aging. Age-standardized death and DALY rates declined between 1990 and 2016 and were lower than in Central Europe but higher than in Western Europe.

Conclusions: Our data suggest a need for national initiatives to improve the diagnosis and treatment of hypertension, slow the progression of HHD, and reduce the related risks and premature deaths.

Citing Articles

Global Burden of Early-Onset Ischemic Heart Disease, 1990 to 2019.

Liu X, Wu Y, Li F, Qi X, Niu L, Wu Y JACC Adv. 2025; 4(1):101466.

PMID: 39811756 PMC: 11731480. DOI: 10.1016/j.jacadv.2024.101466.


Global prevalence and disability-adjusted life years of hypertensive heart disease: A trend analysis from the Global Burden of Disease Study 2019.

Liu A, Lin Y, Meng T, Tian P, Chen J, Zhang X J Glob Health. 2024; 14:04172.

PMID: 39212657 PMC: 11364089. DOI: 10.7189/jogh.14.04172.


Impact of hypertensive heart disease, risk factors, and age-period-cohort models across 204 nations and regions from 1990 to 2019: a global perspective from the 2019 global burden of disease study.

Gao G, Chen Z, Yan G, Bao M Front Cardiovasc Med. 2024; 11:1417523.

PMID: 39091356 PMC: 11291211. DOI: 10.3389/fcvm.2024.1417523.


Persistence of severe global inequalities in the burden of Hypertension Heart Disease from 1990 to 2019: findings from the global burden of disease study 2019.

Lu M, Li D, Hu Y, Zhang L, Li Y, Zhang Z BMC Public Health. 2024; 24(1):110.

PMID: 38184560 PMC: 10771693. DOI: 10.1186/s12889-023-17573-9.


There was a similar U-shaped nonlinear association between waist-to-height ratio and the risk of new-onset hypertension: findings from the CHNS.

Wang Z, Shi Q, Yan X, Tang J, Zhang J Front Nutr. 2023; 10:1304521.

PMID: 38156282 PMC: 10752934. DOI: 10.3389/fnut.2023.1304521.


References
1.
Ayodele O, Alebiosu C, Akinwusi P, Akinsola A, Mejiuni A . Target organ damage and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility. Niger J Clin Pract. 2008; 10(4):319-25. View

2.
Dunlay S, Weston S, Jacobsen S, Roger V . Risk factors for heart failure: a population-based case-control study. Am J Med. 2009; 122(11):1023-8. PMC: 2789475. DOI: 10.1016/j.amjmed.2009.04.022. View

3.
Schocken D, Benjamin E, Fonarow G, Krumholz H, Levy D, Mensah G . Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research.... Circulation. 2008; 117(19):2544-65. DOI: 10.1161/CIRCULATIONAHA.107.188965. View

4.
Cea-Calvo L, Conthe P, Gomez-Fernandez P, de Alvaro F, Fernandez-Perez C . Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study. Cardiovasc Diabetol. 2006; 5:23. PMC: 1636023. DOI: 10.1186/1475-2840-5-23. View

5.
Abegaz T, Tefera Y, Abebe T . Target Organ Damage and the Long Term Effect of Nonadherence to Clinical Practice Guidelines in Patients with Hypertension: A Retrospective Cohort Study. Int J Hypertens. 2017; 2017:2637051. PMC: 5485479. DOI: 10.1155/2017/2637051. View